$AIP

JANAC K CHARLES sold $423K of AIP

JANAC K CHARLES (President and CEO) sold 10,902 shares of Arteris, Inc. (AIP) at $38.78 ($0.42M total) across 4 trades on 2026-07-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · JANAC K CHARLES
Published Jul 6, 2026, 9:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 6, 2026, 9:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AIP
Neutral
high confidence
Mentioned
$AIP
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPNeutralLow
01

Why it matters

Because the sale is open-market and explicitly under a pre-arranged 10b5-1 plan, it is typically treated as lower-signal than discretionary selling; it mainly updates positioning/flow optics.

02

Market read

Traders may monitor for follow-on insider activity, but this disclosure alone does not provide a new fundamental catalyst.

03

What to watch

The filing does not disclose reasons for the sale, and the trades occurred on 2026-07-02 while the market impact would be tied to the filing date.

Relevance 3/10Novelty 4/10Timing: Filed 2026-07-06 after the 2026-07-02 sales under a 10b5-1 plan.

Background

The article is an SEC Form 4 insider transaction: CEO/President Janac K. Charles sold 10,902 AIP shares at ~$38.7779.

Company-level read

Ticker impact

$AIPNeutralHigh confidence
Context

Arteris CEO Janac K. Charles sold $422,756 of AIP shares via an open-market sale under a pre-arranged 10b5-1 plan.

Expected impact

Low near-term impact; any reaction is likely limited to sentiment/flow optics rather than a new company catalyst.

Evidence & confidence

Form 4 shows a planned open-market sale (10b5-1) with no accompanying operational/regulatory/financial update in the filing text.

Market effects

No sector read-through provided; this is company-specific insider transaction data only.

None indicated.

None indicated.

Counterpoint

Insider sales can be interpreted as liquidity management rather than bearish expectations, especially when executed under a 10b5-1 plan.

Key entities

  • Arteris, Inc.

    Subject of the Form 4 insider transaction; CEO/President sold shares under a 10b5-1 plan.

  • JANAC K CHARLES

    President and CEO; reported open-market sale of AIP shares totaling ~$422,756.66.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIPMedAI 8/10

Arteris (AIP) Q2 2026 Earnings Call Transcript

Arteris, Inc. (AIP) reported Q2 2026 revenue of $24.1 million, up 46% year over year. ACV plus royalties were $99.5 million, up 44%, and remaining performance obligation was $135 million, up 36%. Cash and investments rose to $123 million after an at-the-market raise. Full-year 2026 revenue guidance was raised to $95-$98 million.

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris, Inc. (AIP): Results of Operations and Financial Condition

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, to